Annovis Bio, Inc. (ANVS)
NYSE·Healthcare·Biotechnology
$1.79
+3.78%
Mkt Cap $34.43M
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (3 analysts)
$25.67
Range $21.00 – $30.00
Implied Upside
+1338.1%
Consensus $25.67 vs current $1.79
NYSE·Healthcare·Biotechnology
$1.79
+3.78%
Mkt Cap $34.43M
Buy
1
Hold
0
Sell
0
Price Target (3 analysts)
$25.67
Range $21.00 – $30.00
+1338.1%
Consensus $25.67 vs current $1.79